These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12490812)

  • 1. Chronic prostatitis.
    Batstone GR; Doble A
    Curr Opin Urol; 2003 Jan; 13(1):23-9. PubMed ID: 12490812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary approach to prostatitis.
    Magri V; Boltri M; Cai T; Colombo R; Cuzzocrea S; De Visschere P; Giuberti R; Granatieri CM; Latino MA; Larganà G; Leli C; Maierna G; Marchese V; Massa E; Matteelli A; Montanari E; Morgia G; Naber KG; Papadouli V; Perletti G; Rekleiti N; Russo GI; Sensini A; Stamatiou K; Trinchieri A; Wagenlehner FME
    Arch Ital Urol Androl; 2019 Jan; 90(4):227-248. PubMed ID: 30655633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis).
    Nickel JC; Downey J; Pontari MA; Shoskes DA; Zeitlin SI
    BJU Int; 2004 May; 93(7):991-5. PubMed ID: 15142149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic prostatitis and chronic pelvic pain in men: aetiology, diagnosis and management.
    Luzzi GA
    J Eur Acad Dermatol Venereol; 2002 May; 16(3):253-6. PubMed ID: 12195565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptom Severity Following Rifaximin and the Probiotic VSL#3 in Patients with Chronic Pelvic Pain Syndrome (Due to Inflammatory Prostatitis) Plus Irritable Bowel Syndrome.
    Vicari E; Salemi M; Sidoti G; Malaguarnera M; Castiglione R
    Nutrients; 2017 Nov; 9(11):. PubMed ID: 29099760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, incidence estimation, risk factors and characterization of chronic prostatitis/chronic pelvic pain syndrome in urological hospital outpatients in Italy: results of a multicenter case-control observational study.
    Bartoletti R; Cai T; Mondaini N; Dinelli N; Pinzi N; Pavone C; Gontero P; Gavazzi A; Giubilei G; Prezioso D; Mazzoli S; Boddi V; Naber KG;
    J Urol; 2007 Dec; 178(6):2411-5; discussion 2415. PubMed ID: 17937946
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions.
    Hochreiter WW; Nadler RB; Koch AE; Campbell PL; Ludwig M; Weidner W; Schaeffer AJ
    Urology; 2000 Dec; 56(6):1025-9. PubMed ID: 11113752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) symptom evaluation in multinational cohorts of patients with chronic prostatitis/chronic pelvic pain syndrome.
    Wagenlehner FM; van Till JW; Magri V; Perletti G; Houbiers JG; Weidner W; Nickel JC
    Eur Urol; 2013 May; 63(5):953-9. PubMed ID: 23141933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha as possible biomarkers for the chronic pelvic pain syndrome.
    Desireddi NV; Campbell PL; Stern JA; Sobkoviak R; Chuai S; Shahrara S; Thumbikat P; Pope RM; Landis JR; Koch AE; Schaeffer AJ
    J Urol; 2008 May; 179(5):1857-61; discussion 1861-2. PubMed ID: 18353390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexual dysfunction in the patient with prostatitis.
    Müller A; Mulhall JP
    Curr Opin Urol; 2005 Nov; 15(6):404-9. PubMed ID: 16205492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective, 1-year trial using saw palmetto versus finasteride in the treatment of category III prostatitis/chronic pelvic pain syndrome.
    Kaplan SA; Volpe MA; Te AE
    J Urol; 2004 Jan; 171(1):284-8. PubMed ID: 14665895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptoms suggestive of chronic pelvic pain syndrome in an urban population: prevalence and associations with lower urinary tract symptoms and erectile function.
    Marszalek M; Wehrberger C; Hochreiter W; Temml C; Madersbacher S
    J Urol; 2007 May; 177(5):1815-9. PubMed ID: 17437827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chronic prostatitis-chronic pelvic pain syndrome can be characterized by prostatic tissue pressure measurements.
    Mehik A; Hellström P; Nickel JC; Kilponen A; Leskinen M; Sarpola A; Lukkarinen O
    J Urol; 2002 Jan; 167(1):137-40. PubMed ID: 11743292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of quality of life and pain in chronic prostatitis/chronic pelvic pain syndrome: findings from the National Institutes of Health Chronic Prostatitis Cohort Study.
    Berger RE
    J Urol; 2005 Nov; 174(5):1842-3. PubMed ID: 16217306
    [No Abstract]   [Full Text] [Related]  

  • 15. Predictors of patient response to antibiotic therapy for the chronic prostatitis/chronic pelvic pain syndrome: a prospective multicenter clinical trial.
    Nickel JC; Downey J; Johnston B; Clark J;
    J Urol; 2001 May; 165(5):1539-44. PubMed ID: 11342913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated levels of proinflammatory cytokines in the semen of patients with chronic prostatitis/chronic pelvic pain syndrome.
    Alexander RB; Ponniah S; Hasday J; Hebel JR
    Urology; 1998 Nov; 52(5):744-9. PubMed ID: 9801092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the cytokines in genital secretions of patients with chronic prostatitis.
    Paulis G; Conti E; Voliani S; Bertozzi MA; Sarteschi ML; Menchini Fabris F
    Arch Ital Urol Androl; 2003 Dec; 75(4):179-86. PubMed ID: 15005490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
    Magistro G; Wagenlehner FM; Grabe M; Weidner W; Stief CG; Nickel JC
    Eur Urol; 2016 Feb; 69(2):286-97. PubMed ID: 26411805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
    Thakkinstian A; Attia J; Anothaisintawee T; Nickel JC
    BJU Int; 2012 Oct; 110(7):1014-22. PubMed ID: 22471591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How does the pre-massage and post-massage 2-glass test compare to the Meares-Stamey 4-glass test in men with chronic prostatitis/chronic pelvic pain syndrome?
    Nickel JC; Shoskes D; Wang Y; Alexander RB; Fowler JE; Zeitlin S; O'Leary MP; Pontari MA; Schaeffer AJ; Landis JR; Nyberg L; Kusek JW; Propert KJ
    J Urol; 2006 Jul; 176(1):119-24. PubMed ID: 16753385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.